Urology
Volume 8, Issue 5 , Pages 459-464, November 1976

Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma

From the Department of Urology, University of Tennessee Center for the Health Sciences, Memphis, Tennessee, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Presented at the Annual Meeting of the Southeastern Section of the American Urological Association, Inc., Hollywood, Florida, April, 1976.

PII: 0090-4295(76)90275-2

Urology
Volume 8, Issue 5 , Pages 459-464, November 1976

Article Tools